These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 25451127)

  • 21. Intermittent bilateral deep brain stimulation of the nucleus accumbens shell reduces intravenous methamphetamine intake and seeking in Wistar rats.
    Batra V; Tran TL; Caputo J; Guerin GF; Goeders NE; Wilden J
    J Neurosurg; 2017 Apr; 126(4):1339-1350. PubMed ID: 27392268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion.
    Schwendt M; Rocha A; See RE; Pacchioni AM; McGinty JF; Kalivas PW
    J Pharmacol Exp Ther; 2009 Nov; 331(2):555-62. PubMed ID: 19648469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the trace amine associated receptor 1 agonist RO5263397 on abuse-related behavioral indices of methamphetamine in rats.
    Jing L; Zhang Y; Li JX
    Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance.
    Rush CR; Stoops WW; Lile JA; Glaser PE; Hays LR
    Psychopharmacology (Berl); 2011 Apr; 214(3):665-74. PubMed ID: 21072503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global and local morphometric differences in recently abstinent methamphetamine-dependent individuals.
    Schwartz DL; Mitchell AD; Lahna DL; Luber HS; Huckans MS; Mitchell SH; Hoffman WF
    Neuroimage; 2010 May; 50(4):1392-401. PubMed ID: 20096794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural, functional and spectroscopic MRI studies of methamphetamine addiction.
    Salo R; Fassbender C
    Curr Top Behav Neurosci; 2012; 11():321-64. PubMed ID: 22094881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysregulation of D₂-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure.
    Groman SM; Lee B; Seu E; James AS; Feiler K; Mandelkern MA; London ED; Jentsch JD
    J Neurosci; 2012 Apr; 32(17):5843-52. PubMed ID: 22539846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain mGlu5 Is Linked to Cognition and Cigarette Smoking but Does Not Differ From Control in Early Abstinence From Chronic Methamphetamine Use.
    McClintick MN; Kessler RM; Mandelkern MA; Mahmoudie T; Allen DC; Lachoff H; Pochon JF; Ghahremani DG; Farahi JB; Partiai E; Casillas RA; Mooney LJ; Dean AC; London ED
    Int J Neuropsychopharmacol; 2024 Aug; 27(8):. PubMed ID: 39120945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. White matter microstructure and impulsivity in methamphetamine dependence with and without a history of psychosis.
    Uhlmann A; Fouche JP; Lederer K; Meintjes EM; Wilson D; Stein DJ
    Hum Brain Mapp; 2016 Jun; 37(6):2055-67. PubMed ID: 26936688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frontal white matter changes and aggression in methamphetamine dependence.
    Lederer K; Fouche JP; Wilson D; Stein DJ; Uhlmann A
    Metab Brain Dis; 2016 Feb; 31(1):53-62. PubMed ID: 26671551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parallel Effects of Methamphetamine on Anxiety and CCL3 in Humans and a Genetic Mouse Model of High Methamphetamine Intake.
    Huckans M; Wilhelm CJ; Phillips TJ; Huang ET; Hudson R; Loftis JM
    Neuropsychobiology; 2017; 75(4):169-177. PubMed ID: 29402784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct intrinsic functional brain network abnormalities in methamphetamine-dependent patients with and without a history of psychosis.
    Ipser JC; Uhlmann A; Taylor P; Harvey BH; Wilson D; Stein DJ
    Addict Biol; 2018 Jan; 23(1):347-358. PubMed ID: 27917569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methamphetamine use causes cognitive impairment and altered decision-making.
    Mizoguchi H; Yamada K
    Neurochem Int; 2019 Mar; 124():106-113. PubMed ID: 30611760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYP2D6 genotype may moderate measures of brain structure in methamphetamine users.
    Dean AC; Nurmi EL; Morales AM; Cho AK; Seaman LC; London ED
    Addict Biol; 2021 May; 26(3):e12950. PubMed ID: 32767519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methamphetamine reduces expression of caveolin-1 in the dorsal striatum: Implication for dysregulation of neuronal function.
    Somkuwar SS; Fannon MJ; Head BP; Mandyam CD
    Neuroscience; 2016 Jul; 328():147-56. PubMed ID: 27138644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmental perspectives on methamphetamine abuse: Exploring adolescent vulnerabilities on brain and behavior.
    Luikinga SJ; Kim JH; Perry CJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Dec; 87(Pt A):78-84. PubMed ID: 29128447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of action of methamphetamine within the catecholamine and serotonin areas of the central nervous system.
    Chiu VM; Schenk JO
    Curr Drug Abuse Rev; 2012 Sep; 5(3):227-42. PubMed ID: 22998621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamine.
    Downey LA; Loftis JM
    Eur J Pharmacol; 2014 Mar; 727():125-9. PubMed ID: 24485894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment.
    Robertson CL; Ishibashi K; Chudzynski J; Mooney LJ; Rawson RA; Dolezal BA; Cooper CB; Brown AK; Mandelkern MA; London ED
    Neuropsychopharmacology; 2016 May; 41(6):1629-36. PubMed ID: 26503310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered cingulate and insular cortex activation during risk-taking in methamphetamine dependence: losses lose impact.
    Gowin JL; Stewart JL; May AC; Ball TM; Wittmann M; Tapert SF; Paulus MP
    Addiction; 2014 Feb; 109(2):237-47. PubMed ID: 24033715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.